NEUARTIGE THIOPHOSPHORAMIDITE

Patent europeic · EP3728590 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3728590
Numer da la dumonda
EP18830479
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-12-2018
Publitgà
28-10-2020
Concedì
02-07-2025
La protecziun finescha il pli tard
20-12-2038
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C12N 15/11 (2006.01)
C07F 9/165 (2006.01)
C07H 19/10 (2006.01)
C07H 19/20 (2006.01)
C07H 21/00 (2006.01)
Prioritad
WO PCT/CN2017/118043 22.12.2017
EP 18198487 03.10.2018
Dumonda PCT
PCT/EP2018/086457 21.12.2018
Publicaziun PCT
WO2019/122277 27.06.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-05-2026

    Midada

    Published in Swissreg on 18.05.2026

  2. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  3. 02-07-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 02.07.2025

Partidas

Possessur

Roche Innovation Center Copenhagen A/S

Fremtidsvej 3, 2970 Hørsholm, DK

Inventur

BLEICHER, Konrad

4070 Basel

DUSCHMALÉ, Joerg

4070 Basel

DUSCHMALÉ, Martina Brigitte

4126 Bettingen

HANSEN, Henrik Frydenlund

2970 Hørsholm, DK

KOCH, Troels

2970 Hørsholm, DK

LI, Meiling

4070 Basel

SCHAEUBLIN, Adrian

4070 Basel

SHU, Xi

Hubei, 430075, CN

WU, Yong

Hubei, 430075, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.